Overall rank by patents
#10,903
Across all tracked assignees
USPTO PatentsView assignee record - 28 granted patents across 15 technology areas, active 2020–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: F23D (BURNERS).
The verdict
Clearsign holds 28 US patents across 15 technology areas, rank #10,903 of 50,000 tracked assignees.
Clearsign Technologies Corporation has been granted 28 US utility patents between 2020 and 2025, placing Clearsign Technologies Corporation at rank #10,903 across all assignees tracked by PlainPatent. This portfolio spans 15 distinct Cooperative Patent Classification (CPC) subclasses, averaging 34.0 claims per patent with primary concentration in F23D (BURNERS). As a US Corporation, Clearsign Technologies Corporation is one of the more focused assignees in the PatentsView dataset. By volume, Clearsign sits between Cianna Medical, Inc. (28 patents, rank #10,899) and Dispelix OY (28 patents, rank #10,907) - the closest US assignees by grant volume. The composite Innovation Score of 46.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2020 through 2025, with 28 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Clearsign Technologies Corporation's 34.0 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 15 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Clearsign Technologies Corporation against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Cianna Medical, Inc.
28 patents
Clariant Produkte (Deutschland) GmbH
28 patents
Clean Energy Labs, LLC
28 patents
ClearCam, Inc.
28 patents
Comau LLC
28 patents
Comcast Interactive Media, LLC
28 patents
Crystaphase Products, Inc.
28 patents
DISPELIX OY
28 patents
ClearSign Technologies Corporation
28 patents
What this shows Clearsign holds 28 patents at rank #10,903, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #10,903 in granted patent volume.
Other assignees with the most granted patents in Clearsign's primary technology class.
Clearsign's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
46 Top 22% higher than 78% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 10 | 35.7% |
| 2021 | 4 | 14.3% |
| 2022 | 6 | 21.4% |
| 2024 | 6 | 21.4% |
| 2025 | 2 | 7.1% |
Top 15 of 15 technology areas
Overall rank by patents
#10,903
Across all tracked assignees
46.0 out of 100
How to use this portfolio
Clearsign's 28 grants land it in the top 22% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.